Piroxicam
- Generic Name
- Piroxicam
- Brand Names
- Feldene
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13N3O4S
- CAS Number
- 36322-90-4
- Unique Ingredient Identifier
- 13T4O6VMAM
- Background
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
- Indication
For treatment of osteoarthritis and rheumatoid arthritis.
- Associated Conditions
- Ankylosing Spondylitis (AS), Osteoarthritis (OA), Rheumatoid Arthritis
- Associated Therapies
- -
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
- Conditions
- Interventions
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 980
- Registration Number
- NCT06727734
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Riadh Boukef
- Target Recruit Count
- 300
- Registration Number
- NCT06404177
- Locations
- 🇹🇳
Sahloul University Hospital, Sousse, Tunisia
Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 500
- Registration Number
- NCT05722782
- Locations
- 🇹🇳
Fattouma Bourguiba University Hospital, Monastir, Tunisia
Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.
- Conditions
- Interventions
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Farjad Zafar
- Target Recruit Count
- 120
- Registration Number
- NCT05488925
- Locations
- 🇵🇰
Department of Operative Dentistry, Baqai Dental College, Baqai Medical University., Karachi, Sindh, Pakistan
Piroxicam Premedication for Postendodontic Pain in Non-vital Mandibular Molars
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 60
- Registration Number
- NCT03998826
Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 105
- Registration Number
- NCT02450487
Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics
- First Posted Date
- 2014-12-02
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 1400
- Registration Number
- NCT02304783
- Locations
- 🇹🇳
Emergency Department of University Hospital of Monastir, Monastir, Tunisia
A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Pamukkale University
- Target Recruit Count
- 400
- Registration Number
- NCT02253446
- Locations
- 🇹🇷
Pamukkale Universty, Denizli, Turkey
Comparative Study of Olive Oil With Piroxicam Gel in Osteoarthritis of the Knee
- Conditions
- Interventions
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2010-04-29
- Lead Sponsor
- Ardabil University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00670475
- Locations
- 🇮🇷
ArdabiUMS clinic of rheumatology, Ardabil, Iran, Islamic Republic of
A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 154
- Registration Number
- NCT00649415
- Locations
- 🇧🇷
Pfizer Investigational Site, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.